Your browser doesn't support javascript.
loading
Vaso-occlusive crisis pain intensity, frequency, and duration: which best correlates with health-related quality of life in adolescents and adults with sickle cell disease?
McClish, Donna; Okhomina, Victoria; Pascale, Angela; Valrie, Cecelia; Sisler, India; Villella, Anthony; Smith, Wally.
Afiliação
  • McClish D; Departments of Biostatistics and.
  • Okhomina V; Departments of Biostatistics and.
  • Pascale A; Psychology, Virginia Commonwealth University, Richmond, VA, United States.
  • Valrie C; Psychology, Virginia Commonwealth University, Richmond, VA, United States.
  • Sisler I; VCU Institute for Inclusion, Inquiry, and Innovation, Virginia Commonwealth University, Richmond, VA, United States.
  • Villella A; Division of Pediatric Haematology and Oncology, Department of Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, United States.
  • Smith W; Children's Hospital of King's Daughter, Norfolk, VA, United States.
Pain ; 165(1): 135-143, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-37578485
ABSTRACT: In a cross-sectional analysis of baseline data from a randomized clinical trial, we studied 198 adolescents and adults aged 15+ with sickle cell disease. Interest was in assessing the relative strengths of the relationship of vaso-occlusive crisis (VOC) pain domains of intensity, frequency, and duration, with health-related quality of life (HRQOL). Variation in psychosocial, physical function, and pain expression domains of HRQOL was partially explained by frequency, intensity, and duration of VOC pain, separately and together, over and above differences in age, sex, genotype, and organ system damage. However, no single domain measure accounted for more than an additional partial R2 of 12.5% alone. Vaso-occlusive crisis pain frequency explained the most variation, when simultaneously considering VOC intensity and duration, except for stiffness , where duration was most predictive. Yet VOC pain intensity, and even VOC duration, also contributed to variability in HRQOL. We recommend that for most purposes, because all 3 VOC pain domains contribute to variability in HRQOL, all 3 domains should be assessed and interventions should be targeted to improve all 3 domains to maximize HRQOL outcomes (Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT02197845 ).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Orgânicos Voláteis / Anemia Falciforme Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: Pain Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Orgânicos Voláteis / Anemia Falciforme Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans Idioma: En Revista: Pain Ano de publicação: 2024 Tipo de documento: Article